Study reviews chemotherapy method for colorectal cancer after surgery

This research looked at whether giving a specific type of chemotherapy directly into the abdomen during or after curative surgery for colorectal cancer helps patients. The method, called prophylactic intraperitoneal chemotherapy (PIC), uses platinum-based drugs. The goal was to see if it could prevent the cancer from returning in the abdominal lining and improve survival. The analysis combined data from multiple studies involving over 1,200 adults who had surgery with the goal of curing their colorectal cancer. The main finding was that this approach was linked to a significant improvement in disease-free survival, meaning patients stayed cancer-free for longer. Importantly, the analysis did not find an increase in serious side effects or major complications from adding this treatment. However, the results for overall survival—how long patients lived—were not statistically significant, meaning the benefit wasn't clear. The data on preventing cancer recurrence in the abdomen was also mixed and uncertain. This was a review of existing studies, not a new clinical trial. The findings suggest this chemotherapy method shows promise for keeping cancer from coming back, but it hasn't yet been proven to help people live longer. More large, well-designed studies are needed to confirm these results and figure out the best way to use this treatment.